Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study
Open Access
Abstract
Objective To determine the association between use of lipid lowering drugs (statin or fibrate) in older people with no known history of vascular events and long term risk of coronary heart disease and stroke Design Ongoing prospective population based cohort study recruited in 1999-2000, with five face-to-face examinations. Setting Random sample of community dwelling population aged 65 years and over, living in three French cities (Bordeaux, Dijon, Montpellier). Participants 7484 men and women (63%) with mean age 73.9 years and no known history of vascular events at entry. Mean follow-up was 9.1 years. Main outcome measures Adjusted hazard ratios of coronary heart disease and stroke in baseline lipid lowering drug users compared with non-users, calculated using multivariable Cox proportional hazard models adjusted for numerous potential confounding factors. Hazard ratios were estimated for use of any lipid lowering drug and for statin and fibrate separately. Results Lipid lowering drug users were at decreased risk of stroke compared with non-users (hazard ratio 0.66, 95% confidence interval 0.49 to 0.90); hazard ratios for stroke were similar for statin (0.68, 0.45 to1.01) and fibrate (0.66, 0.44 to 0.98). No association was found between lipid lowering drug use and coronary heart disease (hazard ratio 1.12, 0.90 to 1.40). Analyses stratified by age, sex, body mass index, hypertension, systolic blood pressure, triglyceride concentrations, and propensity score did not show any effect modification by these variables, either for stroke or for coronary heart disease. Conclusion In a population based cohort of older people with no history of vascular events, use of statins or fibrates was associated with a 30% decrease in the incidence of stroke.Keywords
This publication has 40 references indexed in Scilit:
- Cholesterol Levels and Risk of Hemorrhagic StrokeStroke, 2013
- Lipid and Lipoprotein Biomarkers and the Risk of Ischemic Stroke in Postmenopausal WomenStroke, 2012
- Serum Lipid Levels and the Risk of Intracerebral Hemorrhage: The Rotterdam StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisThe Lancet, 2010
- Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City StudyAtherosclerosis, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Fibrate TherapyCardiology in Review, 2008
- The CES-D ScaleApplied Psychological Measurement, 1977
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969